OBJECTIVES: The study aims to describe the clinical profile of the adult Fontan survivor and identify the worries, symptoms, and the impact of cardiac surveillance most commonly experienced. DESIGN: A descriptive, cross-sectional design was used. SETTING: The study was performed in outpatient adult and pediatric cardiology clinics in university-affiliated and private practice offices. PATIENTS: Fifty-four adolescent and adult patients with single ventricle congenital heart disease who have undergone the Fontan procedure participated in the study. The mean age was 26 ± 9 years with 52% female and 63% Caucasian. OUTCOME MEASURES: Demographic and clinical data were obtained by a standard intake form and retrospective chart reviews. The Congenital Heart Disease TNO/AZL Adult Quality Of Life questionnaire was completed to assess worries, symptoms, and the impact of cardiac surveillance. RESULTS: The majority were single (73%), employed or full-time students (93%), with health insurance (94%), had a single left ventricle (78%), the diagnosis of tricuspid atresia or double inlet left ventricle (59%), lateral tunnel Fontan type (44%), history of arrhythmias (76%), left ventricle ejection fraction percentage >50 (66%), oxygen saturations >90% (70%), frequent headaches (50%), scoliosis (22%), varicose veins, ascites, and liver cirrhosis (46%), normal body mass index (59%), and New York Heart Association class I (48%) and II-III (52%). Primary worries related to current health (83%), job/employment (69%), ability to work, (61%) and living independently (54%). The most bothersome symptoms were shortness of breath with ambulation (69%), dizziness (61%), and palpitations (61%). CONCLUSIONS: Fontan survivors experience residua and sequelae from multiple surgical procedures and the natural disease course. Our results support the need for ongoing assessment of both physical symptoms and psychosocial concerns, and suggest the need for multiple risk factor intervention strategies that improve physical and emotional health in Fontan survivors.
OBJECTIVES: The study aims to describe the clinical profile of the adult Fontan survivor and identify the worries, symptoms, and the impact of cardiac surveillance most commonly experienced. DESIGN: A descriptive, cross-sectional design was used. SETTING: The study was performed in outpatient adult and pediatric cardiology clinics in university-affiliated and private practice offices. PATIENTS: Fifty-four adolescent and adult patients with single ventricle congenital heart disease who have undergone the Fontan procedure participated in the study. The mean age was 26 ± 9 years with 52% female and 63% Caucasian. OUTCOME MEASURES: Demographic and clinical data were obtained by a standard intake form and retrospective chart reviews. The Congenital Heart DiseaseTNO/AZL Adult Quality Of Life questionnaire was completed to assess worries, symptoms, and the impact of cardiac surveillance. RESULTS: The majority were single (73%), employed or full-time students (93%), with health insurance (94%), had a single left ventricle (78%), the diagnosis of tricuspid atresia or double inlet left ventricle (59%), lateral tunnel Fontan type (44%), history of arrhythmias (76%), left ventricle ejection fraction percentage >50 (66%), oxygen saturations >90% (70%), frequent headaches (50%), scoliosis (22%), varicose veins, ascites, and liver cirrhosis (46%), normal body mass index (59%), and New York Heart Association class I (48%) and II-III (52%). Primary worries related to current health (83%), job/employment (69%), ability to work, (61%) and living independently (54%). The most bothersome symptoms were shortness of breath with ambulation (69%), dizziness (61%), and palpitations (61%). CONCLUSIONS: Fontan survivors experience residua and sequelae from multiple surgical procedures and the natural disease course. Our results support the need for ongoing assessment of both physical symptoms and psychosocial concerns, and suggest the need for multiple risk factor intervention strategies that improve physical and emotional health in Fontan survivors.
Authors: M Kamphuis; J Ottenkamp; H W Vliegen; T Vogels; K H Zwinderman; R P Kamphuis; S P Verloove-Vanhorick Journal: Heart Date: 2002-04 Impact factor: 5.994
Authors: Annemien E van den Bosch; Jolien W Roos-Hesselink; Ron Van Domburg; Ad J J C Bogers; Maarten L Simoons; Folkert J Meijboom Journal: Am J Cardiol Date: 2004-05-01 Impact factor: 2.778
Authors: Matus Petko; Richard J Myung; Gil Wernovsky; Mitchell I Cohen; Jack Rychik; Susan C Nicolson; J William Gaynor; Thomas L Spray Journal: Eur J Cardiothorac Surg Date: 2003-08 Impact factor: 4.191
Authors: M Kamphuis; K H Zwinderman; T Vogels; H W Vliegen; R P Kamphuis; J Ottenkamp; S P Verloove-Vanhorick; J Bruil Journal: Qual Life Res Date: 2004-05 Impact factor: 4.147
Authors: Philip Moons; Leentje De Bleser; Werner Budts; Thierry Sluysmans; Daniel De Wolf; Martial Massin; Marc Gewillig; Agnes Pasquet; Bert Suys; André Vliers Journal: Ann Thorac Surg Date: 2004-04 Impact factor: 4.330
Authors: E H M van Rijen; E M W J Utens; J W Roos-Hesselink; F J Meijboom; R T van Domburg; J R T C Roelandt; A J J C Bogers; F C Verhulst Journal: Eur Heart J Date: 2003-04 Impact factor: 29.983
Authors: Nancy A Pike; Lorraine S Evangelista; Lynn V Doering; Jo-Ann Eastwood; Alan B Lewis; John S Child Journal: Pediatr Cardiol Date: 2012-06 Impact factor: 1.655
Authors: Jill M Steiner; Eric V Krieger; Karen K Stout; April Stempien-Otero; Claudius Mahr; Nahush A Mokadam; Joshua L Hermsen Journal: Int J Cardiol Date: 2017-08-02 Impact factor: 4.164
Authors: Nancy A Pike; Lorraine S Evangelista; Lynn V Doering; Jo-Ann Eastwood; Alan B Lewis; John S Child Journal: J Cardiovasc Nurs Date: 2012 Nov-Dec Impact factor: 2.083
Authors: Karen Uzark; Victor Zak; Peter Shrader; Brian W McCrindle; Elizabeth Radojewski; James W Varni; Kaitlyn Daniels; Jill Handisides; Kevin D Hill; Linda M Lambert; Renee Margossian; Victoria L Pemberton; Wyman W Lai; Andrew M Atz Journal: J Pediatr Date: 2015-12-10 Impact factor: 4.406
Authors: Brian W McCrindle; Victor Zak; Roger E Breitbart; Lynn Mahony; Peter Shrader; Wyman W Lai; Kristin M Burns; Steven D Colan; Richard V Williams; David Goldberg; Kevin D Hill; Svetlana Khaikin; Andrew M Atz Journal: Pediatr Cardiol Date: 2013-11-22 Impact factor: 1.655
Authors: Suraj D Serai; Daniel B Wallihan; Sudhakar K Venkatesh; Richard L Ehman; Kathleen M Campbell; Joshua Sticka; Bradley S Marino; Daniel J Podberesky Journal: Congenit Heart Dis Date: 2013-10-17 Impact factor: 2.007